A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam
Status:
Completed
Trial end date:
2023-08-04
Target enrollment:
Participant gender:
Summary
This study is a single-center, open label phase I clinical study to characterize the DDIs
potential of ZSP1273 With Warfarin and Midazolam in Chinese healthy participants. This study
also aims to evaluate the safety and tolerability of ZSP1273 in the presence of Warfarin and
Midazolam.